tiprankstipranks
Trending News
More News >
RaQualia Pharma Inc. (JP:4579)
:4579
Japanese Market

RaQualia Pharma Inc. (4579) Ratios

Compare
1 Followers

RaQualia Pharma Inc. Ratios

JP:4579's free cash flow for Q4 2025 was ¥0.90. For the 2025 fiscal year, JP:4579's free cash flow was decreased by ¥ and operating cash flow was ¥0.50. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
4.46 4.46 3.82 12.73 9.77
Quick Ratio
4.33 4.33 3.68 12.35 9.75
Cash Ratio
2.54 2.54 2.81 9.54 7.44
Solvency Ratio
0.21 0.21 -0.02 -0.20 1.15
Operating Cash Flow Ratio
-0.28 -0.28 0.15 -1.85 3.00
Short-Term Operating Cash Flow Coverage
-0.60 -0.60 0.35 -56.94 564.92
Net Current Asset Value
¥ 2.06B¥ 2.06B¥ 453.99M¥ 4.20B¥ 4.06B
Leverage Ratios
Debt-to-Assets Ratio
0.28 0.28 0.36 0.05 0.04
Debt-to-Equity Ratio
0.42 0.42 0.62 0.06 0.04
Debt-to-Capital Ratio
0.30 0.30 0.38 0.06 0.04
Long-Term Debt-to-Capital Ratio
0.24 0.24 0.32 <0.01 <0.01
Financial Leverage Ratio
1.52 1.52 1.73 1.12 1.14
Debt Service Coverage Ratio
1.19 1.24 0.07 -7.33 101.81
Interest Coverage Ratio
8.19 8.19 -1.16 -50.50 144.49
Debt to Market Cap
0.13 0.11 0.38 <0.01 <0.01
Interest Debt Per Share
125.93 125.00 168.00 17.33 10.89
Net Debt to EBITDA
-0.36 -0.35 0.60 29.94 -3.44
Profitability Margins
Gross Profit Margin
76.90%82.11%79.86%87.11%92.06%
EBIT Margin
11.26%12.15%-6.87%-15.11%29.37%
EBITDA Margin
23.53%24.42%6.06%-5.88%34.43%
Operating Profit Margin
12.15%12.15%-6.87%-17.74%29.69%
Pretax Profit Margin
11.00%11.00%-11.51%-15.47%29.16%
Net Profit Margin
6.86%6.86%-15.93%-17.02%24.79%
Continuous Operations Profit Margin
6.86%6.86%-15.93%-17.02%24.79%
Net Income Per EBT
62.36%62.36%138.38%110.07%85.00%
EBT Per EBIT
90.54%90.54%167.65%87.16%98.24%
Return on Assets (ROA)
2.60%2.60%-5.13%-4.71%11.56%
Return on Equity (ROE)
4.42%3.96%-8.89%-5.29%13.16%
Return on Capital Employed (ROCE)
5.24%5.24%-2.52%-5.20%15.03%
Return on Invested Capital (ROIC)
3.07%3.07%-2.36%-5.14%12.67%
Return on Tangible Assets
4.03%4.03%-8.60%-4.73%11.61%
Earnings Yield
1.32%1.14%-5.96%-2.18%2.80%
Efficiency Ratios
Receivables Turnover
2.06 2.06 4.51 3.15 4.84
Payables Turnover
12.56 9.73 10.55 4.52 1.81
Inventory Turnover
5.75 4.46 3.73 1.66 27.25
Fixed Asset Turnover
9.12 9.12 5.87 3.31 7.46
Asset Turnover
0.38 0.38 0.32 0.28 0.47
Working Capital Turnover Ratio
0.99 1.03 0.78 0.43 0.74
Cash Conversion Cycle
211.21 221.23 144.18 255.46 -113.11
Days of Sales Outstanding
176.84 176.84 80.95 115.80 75.34
Days of Inventory Outstanding
63.43 81.91 97.83 220.35 13.40
Days of Payables Outstanding
29.06 37.52 34.60 80.69 201.84
Operating Cycle
240.27 258.75 178.78 336.16 88.74
Cash Flow Ratios
Operating Cash Flow Per Share
-15.17 -15.05 8.36 -33.26 70.58
Free Cash Flow Per Share
-18.03 -17.90 3.89 -43.54 69.06
CapEx Per Share
2.86 2.84 4.47 10.28 1.52
Free Cash Flow to Operating Cash Flow
1.19 1.19 0.47 1.31 0.98
Dividend Paid and CapEx Coverage Ratio
-5.29 -5.29 1.87 -3.23 46.39
Capital Expenditure Coverage Ratio
-5.29 -5.29 1.87 -3.23 46.39
Operating Cash Flow Coverage Ratio
-0.12 -0.12 0.05 -1.95 6.66
Operating Cash Flow to Sales Ratio
-0.09 -0.09 0.06 -0.38 0.51
Free Cash Flow Yield
-1.97%-1.77%1.01%-6.33%5.61%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
73.95 87.60 -16.79 -45.93 35.71
Price-to-Sales (P/S) Ratio
5.28 6.01 2.67 7.82 8.85
Price-to-Book (P/B) Ratio
2.93 3.47 1.49 2.43 4.70
Price-to-Free Cash Flow (P/FCF) Ratio
-49.55 -56.43 98.67 -15.80 17.84
Price-to-Operating Cash Flow Ratio
-56.64 -67.09 45.94 -20.69 17.45
Price-to-Earnings Growth (PEG) Ratio
0.54 -0.58 -0.32 0.32 -8.20
Price-to-Fair Value
2.93 3.47 1.49 2.43 4.70
Enterprise Value Multiple
22.07 24.27 44.74 -103.02 22.28
Enterprise Value
21.14B 23.59B 8.42B 11.52B 22.38B
EV to EBITDA
22.57 24.27 44.74 -103.02 22.28
EV to Sales
5.31 5.93 2.71 6.06 7.67
EV to Free Cash Flow
-49.85 -55.63 100.00 -12.24 15.45
EV to Operating Cash Flow
-59.27 -66.14 46.56 -16.03 15.12
Tangible Book Value Per Share
134.54 133.54 77.07 281.85 260.98
Shareholders’ Equity Per Share
293.30 291.12 257.35 283.27 262.14
Tax and Other Ratios
Effective Tax Rate
0.38 0.38 -0.38 -0.10 0.15
Revenue Per Share
169.27 168.01 143.57 87.99 139.16
Net Income Per Share
11.62 11.53 -22.87 -14.98 34.50
Tax Burden
0.62 0.62 1.38 1.10 0.85
Interest Burden
0.98 0.91 1.68 1.02 0.99
Research & Development to Revenue
0.40 0.40 0.55 0.72 0.43
SG&A to Revenue
0.00 0.00 0.32 0.33 0.20
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.00 0.00
Income Quality
-1.31 -1.31 -0.37 2.22 1.74
Currency in JPY